Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
Kyle L O’Donnell, Andrea Marzi Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USACorrespondence: Andrea Marzi Email marzia@niaid.nih.govAbstract: Ebola virus disease (EVD) remains...
Guardado en:
Autores principales: | O'Donnell KL, Marzi A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be1614737e824619a0a6e0158cf18527 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
por: J. Maximilian Fels, et al.
Publicado: (2019) -
Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
por: Emily Speranza, et al.
Publicado: (2020) -
Modeling Ebola Virus Transmission Using Ferrets
por: Marc-Antoine de La Vega, et al.
Publicado: (2018) -
MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
por: E. I. Kazachinskaia, et al.
Publicado: (2014) - Monoclonal antibodies in immunodiagnosis and immunotherapy